120568-11-8,
5-[2-(4'-Methylbiphenyl)]tetrazole,
5-(4'-methylbiphenyl-2-yl)-1H-tetrazole,
UNII-ECZ29UKI0W,
5-(4'-Methyl-2-biphenyl)tetrazole,
ECZ29UKI0W,
5-(4'-Methyl-1,1'-biphen-2-yl)-1H-tetrazole,
L-158507,
5-(4'-Methylbiphenyl-2-yl)-2H-tetrazole,
5-[2-(4-methylphenyl)phenyl]-2H-tetrazole,
5-(4'-Methyl-1,1'-biphenyl-2-yl)-1H-tetrazole,
5-(2-(4'-Methylbiphenyl))tetrazole,
5-(4'-Methyl-[1,1'-biphenyl]-2-yl)-1h-tetrazole,
1H-Tetrazole, 5-(4'-methyl[1,1'-biphenyl]-2-yl)-,
Losartan potassium impurity E [EP],
Losartan Impurity E,
Methylbiphenyl Tetrazole,
SCHEMBL1774035,
SCHEMBL8171721,
2H-Tetrazole, 5-(4'-methyl(1,1'-biphenyl)-2-yl)-,
CHEMBL1908064,
BDBM36634,
DTXSID40152911,
VWOJMXKARYCRCC-UHFFFAOYSA-N,
ZINC2570854,
CM-214,
MFCD00870018,
5-(4'-methylbiphenyl-2-yl)tetrazole,
AKOS000278514,
AKOS032947897,
RP17377,
SB13063,
4-Methyl-2'-[1H-tetrazol-5-yl]biphenyl,
5-(4'-methyl biphenyl-2-yl)-1H-tetrazole,
5-(4'-Methyl-biphenyl-2-yl)-2H-tetrazole,
5-[2-(4-methylphenyl)phenyl]-1H-tetrazole,
FT-0653470,
2-(tetrazol-5-yl)-4'-methyl-1,1'-biphenyl,
459M510,
A804537,
A1-03006,
I01-2060,
J-516265,
2H-Tetrazole,5-(4'-methyl[1,1'-biphenyl]-2-yl)-,
5-(4'-Methyl[1,1'-biphenyl]-2-yl)-1H-tetrazole,
L-158,507,
5-[2-(4-methylphenyl)phenyl]-1H-1,2,3,4-tetrazole,
5-[2-(4-methylphenyl)phenyl]-2H-1,2,3,4-tetrazole,
Z2235812862,
5-{4'-methyl-[1,1'-biphenyl]-2-yl}-1H-1,2,3,4-tetrazole,
CID9794697,
5-(4/'-Methylbiphenyl-2-yl)-1H-tetrazole,